LOGIN 

 

JOIN

 

RENEW

Pediatric

Neuromuscular disorders

Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct. PMID: 30275250

Sawnani H. Sleep disordered breathing in Duchenne muscular dystrophy. Paediatr Respir Rev. 2019 Apr; PMID: 30153979

Grace R Paul, Courtney Gushue, Kavitha Kotha, Richard Shell. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol 2020 Oct 24. PMID: 33098622

Finder J, Mayer OH, Sheehan D, Sawnani H, Abresch RT, Benditt J, Birnkrant DJ, Duong T, Henricson E, Kinnett K, McDonald CM, Connolly AM.Finder J, et al. Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary. Am J Respir Crit Care Med. 2017 Aug 15; Am J Respir Crit Care Med. 2017. PMID: 28636407

Panitch HB. Respiratory Implications of Pediatric Neuromuscular Disease. Respir Care. 2017 Jun;62(6):826-848.

Katz SL1. Assessment of sleep-disordered breathing in pediatric neuromuscular diseases. Pediatrics. 2009 May;123 Suppl 4:S222-5. doi: 10.1542/peds.2008-2952E.

Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, Lowes L, Alfano L, Berry K, Church K, Kissel JT, Nagendran S, L'Italien J, Sproule DM, Wells C, Cardenas JA, Heitzer MD, Kaspar A, Corcoran S, Braun L, Likhite S, Miranda C, Meyer K, Foust KD, Burghes AHM, Kaspar BK. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N Engl J Med. 2017 Nov 2;377(18):1713-1722. doi: 10.1056/NEJMoa1706198.